Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
about
A comprehensive overview of radioguided surgery using gamma detection probe technologyDeglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function.Cancer targeted therapeutics: From molecules to drug delivery vehicles.124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4In vitro gastric cancer cell imaging using near-infrared quantum dot-conjugated CC49Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.Synthesis of CdTe quantum dot-conjugated CC49 and their application for in vitro imaging of gastric adenocarcinoma cellsA metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.Monoclonal antibody B72.3 in benign breast lesions.Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment.A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic Colorectal Cancer Model.Characterization of OM-B monoclonal antibody-defined antigen associated with mucinous type human ovarian tumor.
P2860
Q21245578-6964D196-E832-4EE4-BCA4-C603F7FD687DQ30333497-45D111C0-5B74-42C0-B1E3-3C814863352EQ33887986-9A14C543-1D41-4E63-80C4-060E86146F5DQ34075225-2D9A0441-17C1-461D-AC33-EFD18DDFFB79Q34126535-28882664-B975-49AB-9CEF-8C64F1545724Q34555580-F18CB10A-3D9A-4D30-BBC6-D247AAB23708Q35983215-9712561D-E933-4542-9AC4-D1323D97E985Q36403435-45FEAE05-07EB-4DAB-A167-53E1EE927448Q36939943-AB7A8953-2C65-4E07-AF22-1A33DDD2C1CBQ36964315-BB644C68-41B1-4F5A-A3C9-A1769480C12BQ37070130-F63B3908-3ABD-4AB3-9E2F-3A7B7EE2B5B2Q37269599-343B5434-5DBF-42E0-B4DA-147A1157774CQ41870446-436C3C8F-8BCF-4C3C-AEE7-7C357BAC7406Q50927984-CD1DDBFA-A4C0-4214-83FF-8544078B16CDQ55265613-3D3C256E-6756-4BDC-BB13-027CAB493F97
P2860
Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
Purification and composition o ...... nal antibodies CC49 and B72.3.
@ast
Purification and composition o ...... nal antibodies CC49 and B72.3.
@en
Purification and composition of the human tumor-associated glycoprotein
@nl
type
label
Purification and composition o ...... nal antibodies CC49 and B72.3.
@ast
Purification and composition o ...... nal antibodies CC49 and B72.3.
@en
Purification and composition of the human tumor-associated glycoprotein
@nl
prefLabel
Purification and composition o ...... nal antibodies CC49 and B72.3.
@ast
Purification and composition o ...... nal antibodies CC49 and B72.3.
@en
Purification and composition of the human tumor-associated glycoprotein
@nl
P2093
P1433
P1476
Purification and composition o ...... nal antibodies CC49 and B72.3.
@en
P2093
P304
P407
P577
1988-12-01T00:00:00Z